Clinical and genetic heterogeneity in Omenn syndrome and severe combined immune deficiency

Pediatr Transplant. 2009 Mar;13(2):244-50. doi: 10.1111/j.1399-3046.2008.00970.x. Epub 2008 Sep 5.

Abstract

OS has been described as a clinical phenotype in infants characterized by SCID, diffuse erythroderma, and other distinct features. The pathogenesis is secondary to autologous, auto-reactive T cells produced as rare escapees from the SCID blockade. Mutations in either the RAG1 or RAG2 gene that lead to partial recombinase activity are responsible for many of the patients with these clinical features. We report on two patients, one with an atypical phenotype of OS (absence of rash but presence of other typical features) who harbored a previously undescribed mutation in RAG1, and a second who had many of the classic features of OS but was found to have a mutation in the common gamma chain (gamma(c)) cytokine receptor gene. These cases highlight the clinical and genetic heterogeneity of OS.

Publication types

  • Case Reports

MeSH terms

  • Cytokines / genetics
  • Exanthema / genetics
  • Female
  • Homeodomain Proteins / genetics
  • Humans
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / genetics*
  • Immunologic Deficiency Syndromes / immunology*
  • Infant
  • Male
  • Models, Genetic
  • Mutation
  • Phenotype
  • Severe Combined Immunodeficiency / complications
  • Severe Combined Immunodeficiency / genetics*
  • Severe Combined Immunodeficiency / immunology*
  • T-Lymphocytes / metabolism
  • Time Factors
  • Treatment Outcome
  • VDJ Recombinases / genetics

Substances

  • Cytokines
  • Homeodomain Proteins
  • RAG-1 protein
  • VDJ Recombinases